New Retatrutide Study Published in Journal of Molecular Histology

On October 15, 2026, a new publication involving retatrutide appeared in the Journal of Molecular Histology. The study is titled "Retatrutide treatment in streptozotocin-induced diabetic rats: renal inflammatory cytokines, HIF-1α expression, and histopathological injury profile." It was indexed under PubMed ID 42878930. The publication examines retatrutide treatment in a streptozotocin-induced diabetic rat model, with a focus on renal inflammatory cytokines, HIF-1α expression, and histopathological injury profile, according to the title. No findings, results, or conclusions from the study have been reported here. This brief reflects only the existence and title of the publication as listed in the source record. Readers interested in the full methodology and results should consult the journal article directly. For additional background on retatrutide, including its regulatory status and general information, readers can refer to the compound overview.